FISCALNOTE HOLDINGS INC (NOTE)

US3376551046 - Common Stock

0.8675  +0.08 (+9.94%)

After market: 0.8822 +0.01 (+1.69%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOTE. NOTE was compared to 81 industry peers in the Professional Services industry. NOTE may be in some trouble as it scores bad on both profitability and health. NOTE is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

NOTE had negative earnings in the past year.
In the past year NOTE has reported a negative cash flow from operations.

1.2 Ratios

NOTE has a Return On Assets of -31.16%. This is amonst the worse of the industry: NOTE underperforms 92.21% of its industry peers.
The Return On Equity of NOTE (-265.67%) is worse than 93.51% of its industry peers.
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROIC N/A
ROA(3y)-56.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NOTE's Gross Margin of 81.61% is amongst the best of the industry. NOTE outperforms 88.31% of its industry peers.
In the last couple of years the Gross Margin of NOTE has remained more or less at the same level.
NOTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

NOTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOTE has less shares outstanding than it did 1 year ago.
NOTE has a worse debt/assets ratio than last year.

2.2 Solvency

NOTE has an Altman-Z score of -3.17. This is a bad value and indicates that NOTE is not financially healthy and even has some risk of bankruptcy.
NOTE has a Altman-Z score of -3.17. This is amonst the worse of the industry: NOTE underperforms 93.51% of its industry peers.
NOTE has a Debt/Equity ratio of 5.12. This is a high value indicating a heavy dependency on external financing.
NOTE has a Debt to Equity ratio of 5.12. This is amonst the worse of the industry: NOTE underperforms 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF N/A
Altman-Z -3.17
ROIC/WACCN/A
WACC10.55%

2.3 Liquidity

A Current Ratio of 0.76 indicates that NOTE may have some problems paying its short term obligations.
With a Current ratio value of 0.76, NOTE is not doing good in the industry: 88.31% of the companies in the same industry are doing better.
NOTE has a Quick Ratio of 0.76. This is a bad value and indicates that NOTE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.76, NOTE is not doing good in the industry: 88.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76

4

3. Growth

3.1 Past

NOTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
The Revenue has grown by 16.56% in the past year. This is quite good.
NOTE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.71% yearly.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5YN/A
Sales Q2Q%-13.43%

3.2 Future

NOTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.08% yearly.
Based on estimates for the next years, NOTE will show a decrease in Revenue. The Revenue will decrease by -1.21% on average per year.
EPS Next Y108.99%
EPS Next 2Y26.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9%
Revenue Next 2Y-1.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

NOTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

NOTE's earnings are expected to grow with 26.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.08%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NOTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FISCALNOTE HOLDINGS INC

NYSE:NOTE (11/21/2024, 8:04:01 PM)

After market: 0.8822 +0.01 (+1.69%)

0.8675

+0.08 (+9.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap122.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 81.61%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y108.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y